Health Insurance Bureau: strictly check the price competition, bidding can not be lower than the cost price! Six types of cases will be processed!

Pharmaceutical Network July 16th, July 13, Heilongjiang Medical Insurance Bureau issued the "Heilongjiang Province drug and medical supplies centralized procurement and price supervision and inspection measures (trial)" (hereinafter referred to as "Measures"), pointing out that bidders participating in drug procurement bids may not bid at below-cost bids, not by fraud, bid rigging, abuse of market dominance, etc., and stipulated that drug market licensing holders, pharmaceutical manufacturers, drug manufacturers, etcto participate in centralized procurement of drugs The six categories of violations of pharmaceutical enterprises will be dealt with by the medical security department in accordance with the lawThe Measures for the strict investigation of improper competition state that if the holder of a drug market license, a pharmaceutical production enterprise, a pharmaceutical enterprise and its staff involved in the centralized procurement of drugs has one of the following acts, the medical security department shall deal with it according to law: providing false supporting documents or otherwise falsifying it; Non-force majeure withdrawal or refusal to sign a procurement contract with a medical institution; unauthorized price increase or disguised price increase during the procurement cycle; unauthorized distribution of non-finalist drugs, non-distribution of drugs in accordance with the contract, or distribution in violation of the relevant provisions; and other illegal and illegal actsThe Measures make it clear that the State shall establish and improve the drug price monitoring system, monitor drug prices, conduct cost price investigations, strengthen drug price supervision and inspection, investigate and punish illegal acts of price monopoly and price hikes, and maintain the order of drug prices in accordance with the lawThe medical security departments at all levels shall, in accordance with law, carry out supervision and inspection of the holders of drug market licenses, pharmaceutical production enterprises, pharmaceutical enterprises and medical institutions to provide the competent departments of drug prices with information on the actual purchase and sale price of their medicines and the quantity purchased and sellingIn addition to the control of drug prices, the Measures also provide that for medical supplies production and operation enterprises have "malicious bidding at prices below the cost, disrupting market order; The implementation of medical supplies production and operation enterprises bad record dynamic management system and other pharmaceutical prices and recruitment credit evaluation systemIf a medical supplies production and operation enterprise has one of the following acts, it shall be included in the bad record and published online, the entry qualification of all the products of the enterprise shall be cancelled, and within two years from the date of cancellation, the centralized purchasing authority shall not accept any of its product centralized procurement applications, and the public medical institutions of the province shall not purchase their products in any form, and the original contract of purchase and sale shall be terminated(1) After the law enforcement and discipline authorities determined that there was commercial bribery in the purchase and sale of high-value medical supplies; (2) providing false and invalid documents; (3) falsifying and defrauding the finalists; (4) making malicious bids at prices below cost to disrupt market order; (5) unauthorized or disguised price increases on the shortlisted varieties; (6) non-distribution or non-delivery of shortlisted varieties, affecting clinical medical treatment and treatment by medical institutions; Packaging and other information are inconsistent with the specifications of the shortlisted varieties, packaging and other information and do not agree to replacement; (8) replacing the finalists with high-value medical supplies outside the finalists for distribution; (9) violating the existing medical device price management regulations; (10) malicious complaints, disturbing the normal order of centralized procurement; and (11) other circumstances prescribed by the centralized procurement management agencyNot only low-cost selection in the industry's view, drug tape procurement after a year and a half of practice exploration, "price reduction is the hard truth" concept has been deeply rooted in the peopleAt the same time, "not only low-cost selection" of a number of selected, enterprises reasonable quotation, but also gradually normal, institutionalized, reasonable bidding, to avoid vicious competition will become the next collection of the "main melody." On July 7, Hebei Medical Insurance Bureau issued a "notice on further strengthening the management of centralized procurement work and related issues" pointed out that the provincial health insurance bureau to the province's centralized procurement work to carry out overall planning, to avoid centralized procurement work "local fight" "variety fight" problemCentralized procurement rules should be designed scientifically and rationally, respect market laws, do not engage in price reduction competition, not only low prices are takenProduct grouping should not be over-detailed, quality layering to be fair and just, not because of the rules of the interests of defects, affecting the final resultsIn fact, before Hebei, Shandong Medical Insurance Bureau also issued a regulation of drugs and medical supplies procurement work related notice, clear at all levels of the collection of varieties can not crashAt the same time also requires the implementation of the "true belt volume", so that enterprises have a clear sales expectations, and the agreed procurement volume to implement to every hospital, not false band volume, to prevent the emergence of "gold sales" gray spaceIndustry insiders pointed out that in recent years, many provinces and cities to implement the price linkage "priceless", in the bidding only low price is to take, but the price is "interest regulator", related to the cost of purchase and development of the interests, is to balance the market and manufacturers of the development of the fulcrumReasonable market competition mechanism should be stable and dynamicIt can be imagined that in the future, the provinces of the recruitment program mandatory set the possibility of a decline in the shortlist will be less and less, instead of the lowest procurement price on the basis of independent competition by enterprises, reasonable quotation